Run
198175

Run 198175

Task 1777 (Supervised Classification) breast-cancer Uploaded 27-02-2015 by Joaquin Vanschoren
0 likes downloaded by 0 people 0 issues 0 downvotes , 0 total downloads
Issue #Downvotes for this reason By


Flow

weka.SPegasos(5)S. Shalev-Shwartz, Y. Singer, N. Srebro: Pegasos: Primal Estimated sub-GrAdient SOlver for SVM. In: 24th International Conference on MachineLearning, 807-814, 2007.
weka.SPegasos(5)_F0
weka.SPegasos(5)_L1.0E-4
weka.SPegasos(5)_E500

Result files

xml
Description

XML file describing the run, including user-defined evaluation measures.

model
Model readable

A human-readable description of the model that was built.

model
Model serialized

A serialized description of the model that can be read by the tool that generated it.

arff
Predictions

ARFF file with instance-level predictions generated by the model.

22 Evaluation measures

0.5233
Per class
Cross-validation details (5 times 2-fold Crossvalidation)
0.4166
Per class
Cross-validation details (5 times 2-fold Crossvalidation)
0.0328
Cross-validation details (5 times 2-fold Crossvalidation)
-683.0993
Cross-validation details (5 times 2-fold Crossvalidation)
0.5755
Cross-validation details (5 times 2-fold Crossvalidation)
0.4183
Cross-validation details (5 times 2-fold Crossvalidation)
1430
Per class
Cross-validation details (5 times 2-fold Crossvalidation)
[Oracle Corporation, 1.7.0_75, amd64, Linux, 3.16.0-29-generic]
0.612
Per class
Cross-validation details (5 times 2-fold Crossvalidation)
0.4245
Cross-validation details (5 times 2-fold Crossvalidation)
0.8796
Cross-validation details (5 times 2-fold Crossvalidation)
0.4245
Per class
Cross-validation details (5 times 2-fold Crossvalidation)
1.3758
Cross-validation details (5 times 2-fold Crossvalidation)
0.457
Cross-validation details (5 times 2-fold Crossvalidation)
0.7586
Cross-validation details (5 times 2-fold Crossvalidation)
1.6599
Cross-validation details (5 times 2-fold Crossvalidation)
1363.454
80
Cross-validation details (5 times 2-fold Crossvalidation)
80
Cross-validation details (5 times 2-fold Crossvalidation)